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Background: Medication reconciliation can reduce adverse events associated with prescribing errors at transitions
between sites of care. Though a U.S. Joint Commission National Patient Safety Goal since 2006, at present
organizations continue to have difficulty implementing it. The objective of this study was to examine medication
reconciliation implementation from the perspective of individuals involved in the planning process in order to
identify recurrent themes, including facilitators and barriers, that might inform other organizations’ planning and
implementation efforts.
Methods: We performed semi-structured interviews with individuals who had a role in planning medication
reconciliation implementation at a large urban academic medical center in the U.S. and its affiliated Veterans Affairs
hospital. We queried respondents’ perceptions of the implementation process and their experience with facilitators and
barriers. Transcripts were coded and analyzed using a grounded theory approach. The themes that emerged were
subsequently categorized using the Consolidated Framework for Implementation Research (CFIR).
Results: There were 13 respondents, each with one or more organizational roles in quality improvement, information
technology, medication safety, and education. Respondents described a resource- and time- intensive medication
reconciliation planning process. The planning teams’ membership and functioning were recognized as important
factors to a successful planning process. Implementation was facilitated by planners’ understanding of the principles of
performance improvement, in particular, fitting the new process into the workflow of multiple disciplines. Nevertheless,
a need for significant professional role changes was recognized. Staff training was recognized to be an important
part of roll-out, but training had several limitations. Planners monitored compliance to help sustain the process, but
acknowledged that this did not ensure that medication reconciliation actually achieved its primary goal of reducing
errors. Study findings fit multiple constructs in the CFIR model.
Conclusions: Study findings suggest that to improve the likelihood of a successful implementation of medication
reconciliation, planners should, among other considerations, involve a multidisciplinary planning team, recognize the
significant professional role changes that may be needed, and consider devoting resources not just to compliance
monitoring but also to monitoring of the process’ impact on prescribing.
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Over the last decade, patient safety in the healthcare
system has received increased attention from the med-
ical community. An Institute of Medicine report from
2000 highlighted that 44,000-98,000 deaths per year
could be attributed to preventable errors in healthcare
delivery [1]. Observational studies have found that ad-
verse events occur in 2-4% of hospitalized patients [2].
Of these, drug complications are the most common
type, with 20% or more being medication-related;
i.e., adverse drug events (ADEs) [3,4].
Evidence suggests that medication reconciliation can
reduce ADEs associated with transitions within and be-
tween healthcare settings, especially for patients who
are at higher risk because of older age, multiple chronic
conditions, or use of many medications [5-7]. Medica-
tion reconciliation is the process of creating a best pos-
sible list of medications being used by a patient and
comparing that list with the provider’s admission, trans-
fer, and/or discharge orders. This occurs in 3 steps: ve-
rification (collecting the patient’s medication history),
clarification (ensuring that the medications and doses
are appropriate), and reconciliation (documenting changes
in the orders) [8,9]. Since nearly 30% of prescribing errors
are associated with incomplete medication histories on
admission [10], a focus of this process is to reduce pre-
scribing errors at hospital admission and discharge. In
one study, medication reconciliation was shown to de-
crease ADEs caused by admission prescribing errors by
43% [11]. A systematic review suggests that the most ef-
fective medication reconciliation interventions are those
that utilize pharmacy staff and focus on patients at high
risk for adverse events [6].
The Joint Commission, an independent non-profit
accreditation body of hospital systems, introduced
medication reconciliation as a National Patient Safety
Goal in 2006 [8]. Despite an extensive effort on the
part of many organizations to implement it within vari-
ous healthcare settings, implementation has been chal-
lenging [12]. After temporarily removing medication
reconciliation from the list of National Patient Safety
Goals, The Joint Commission brought it back again in
2011. Within this background, the objective of this
study was to perform a qualitative examination of the
medication reconciliation planning process in two
healthcare organizations. We report on factors affect-
ing implementation from the perspectives of those in-
volved in planning, including physician managers,
nurse managers, quality specialists, pharmacy man-
agers, information technologists. We also indicate how
emergent themes fit into constructs in a healthcare imple-
mentation model [13] and discuss how these findings
could to inform organizations’ ongoing implementation
efforts.Methods
Study design
This qualitative study utilized key informant interviews
with individuals involved in planning medication recon-
ciliation implementation at two healthcare organizations,
and used a grounded theory approach [14]. We chose to
use individual semi-structured interviews as opposed to
closed-ended survey questions to better explore respon-
dents’ perspectives. Individual interviews were utilized in
favor of focus groups to foster respondents’ freedom of
expression without self-censoring.
Setting and timing
The settings were a large urban academic tertiary care
center and an affiliated Veterans Affairs (VA) hospital in
New York City. At the time of the study, the medication
reconciliation planning and implementation process had
taken place approximately three years prior (i.e., the in-
patient medication reconciliation procedure had been in
place for three years).
Respondents
Respondents were recruited who were involved in the
medication reconciliation planning process, selected from:
pharmacy directors, chiefs of staff, nurse managers, quality
improvement managers, information technology represen-
tatives, and physicians with administrative roles. Potential
respondents were members of standing or ad hoc plan-
ning committees such as quality improvement, patient
safety, information technology, and risk management
committees, and were recruited by email and telephone.
We used a snowball sampling strategy in which initial
respondents were asked to refer us to additional poten-
tial respondents, and we continued recruiting respon-
dents until there were no further individuals involved in
the medication reconciliation planning process to inter-
view. Respondents provided written informed consent,
and the protocol was approved by the Institutional Review
Boards of the James J. Peters VA Medical Center and Icahn
School of Medicine at Mount Sinai in New York City.
Data collection
Interviews took place in or near the respondents’ own
offices and were conducted by two research team mem-
bers. The primary interviewer (SLS) used an interview
guide of semi-structured questions and probes while a
second interviewer (KSB) asked additional clarifying
questions. The interviewers explored respondents’ per-
ceptions of the medication reconciliation implementa-
tion planning process and their attitudes regarding its
purpose. They were questioned on the optimal roles in
the process for physicians, nurses, pharmacists and other
members of the healthcare team. They were asked about
facilitators and barriers to planning and implementation
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debriefed after each interview to identify additional po-
tential areas of exploration and focus for subsequent in-
terviews. Interviews were 30 to 60 minutes in length,
were audiotaped, and were transcribed verbatim. Only
one author (KSB) had access to the file linking tran-
scripts with respondents’ identities.
Data analysis
Transcripts were analyzed using a grounded theory ap-
proach [15-17]. Using multiple close readings, two research
team members (SLS and KSB) reviewed the interviews in-
dependently to generate a list of concepts and domains and
to determine a preliminary coding scheme. Codes were de-
rived from a combination inductive approach using a con-
stant comparison method [14]. To test the preliminary
scheme, an initial transcript was independently coded by
two investigators and the scheme revised. Discussion
among all four investigators yielded a final coding scheme.
Two team members (SHS and SSS) then applied the codes
to each transcript by labeling individual words or phrases
on hard copy. Consistency and reliability was repeatedly
assessed by having the coders review a randomly selected
set of transcript passages in duplicate and reconcile dis-
agreement by discussion, with input from a third team
member. The coded transcripts were entered into software
Atlas.ti version 5.2 (Berlin, Germany) to facilitate sorting
of passages. Research team members compared codes
within and across interviews to elucidate themes. Quota-
tions were chosen that were illustrative of each theme.
Themes were then labeled using constructs in the Consol-
idated Framework for Implementation Research (CFIR),
which was selected because it combines constructs across
multiple published implementation theories [13]. This re-
port adheres to the BioMed Central guideline (RATS) for
reporting qualitative studies [18].
Results
Characteristics of respondents
Of 14 individuals invited to participate, one was unavail-
able to be interviewed. Of the 13 interview respondents
12 reported participating directly in the medication rec-
onciliation planning process while one became involved
in medication reconciliation after implementation was
already underway. Respondents had the following de-
partment or committee roles: quality improvement (4),
information technology (4), medication safety (3), and
education (2). They had on average 5.9 (SD = 3.7) years
of experience in their current position and all except
one were present in their current position at the time
the medication reconciliation implementation process
had taken place. By professional training, there were four
physicians, four nurses, four pharmacists, and one infor-
mation technologist.Theme 1
Respondents recognized the value of medication recon-
ciliation in improving patient safety and reducing medica-
tion errors, but respondents also had a broader view of its
value that motivated them to contribute to the planning
process.
Respondents indicated a high level of agreement that
the purpose of medication reconciliation is to improve
patient safety by preventing errors in medication
history-taking, recording, and decision-making. Several
respondents indicated that medication reconciliation has
additional value in that it increases patient dialogue and
education, promotes communication between healthcare
providers, and mitigates risks at transfer points:
The purpose of medication reconciliation is in a
global way to provide safe care because when the
patient comes into the hospital we’ve come to realize
we need to have a firm understanding of the
medications the patients have been taking at home,
and the importance of it has risen (Nurse Manager).
Respondents were motivated to participate in the
medication reconciliation planning process by a belief
that medication reconciliation is inherently proper med-
ical management, not just because it is a Joint Commis-
sion standard: “This is one of the few things that is
mandated that has a value” (Pharmacist Manager).
A few respondents observed that medication recon-
ciliation also forces physicians to make individual active
prescribing decisions for each and every medication and
bring increased cognitive focus to their prescribing
decisions:
It forces the provider to say is this drug therapy still
consistent with the patient's current medical
condition, should it be continued at this time or not,
and should it be reinstituted when the patient goes
home (Pharmacist Manager).
These quotes reflect planners’ knowledge and beliefs
about medication reconciliation, and reflect the influ-
ence of such beliefs on the implementation planning
process, a core CFIR construct (Table 1).
Theme 2
The planning teams’ membership and functioning were
recognized as facilitators to a successful medication recon-
ciliation planning process.
A majority of respondents agreed that the planning
team had to be multidisciplinary; i.e., to include stake-
holders in medical, nursing, pharmacy, and information
technology departments, as well as relevant committee
members (e.g. patient safety, quality improvement, and
Table 1 Themes, facilitators, and barriers to implementing medication reconciliation according to qualitative analysis of interviews with healthcare managers,
and selected relevant Consolidated Framework for Implementation Research (CFIR) constructs [13]
Facilitator Barrier CFIR construct(s) with short definition [13]
Theme 1: Consensus that purpose of medication reconciliation is to improve patient safety; respondents also had a broader view of its value
Planners with a broad view of the process’ value Individuals’ knowledge and beliefs about the intervention: “attitudes toward and value placed
on the intervention as well as familiarity with facts, truths, and principles related to the
intervention” [13]
External policy and incentives: “external strategies to spread interventions including policy
and regulations (governmental or other central entity), external mandates, … and public or
benchmark reporting” [13]
Theme 2: Planning team’s membership and functioning recognized as facilitators to a successful planning process
Planners who were or became champions of the process Engaging champions: “’individuals who dedicate themselves to supporting, marketing, and
“driving through” an [implementation]’, overcoming indifference or resistance that the
intervention may provoke in an organization” [13]
Planners organizationally positioned to carry out the plan Engaging individuals: “attracting and involving appropriate individuals in the
implementation” [13]
Planners who were compelling leaders, who could get
buy-in from front line staff
Engaging opinion leaders: “individuals in an organization who have formal or informal
influence on the attitudes and beliefs of their colleagues with respect to implementing the
intervention” [13]
Planners with openness to others’ perspectives and a
willingness to compromise, to facilitate discussion and joint
problem-solving
Learning climate: “climate in which leaders express their own fallibility and need for team
members’ assistance and input; team members feel that they are essential, valued, and
knowledgeable partners in the change process; individuals feel psychologically safe to try new
methods; …sufficient time and space for reflective thinking and evaluation” [13]
Perseverance in obtaining resources Lack of resources, staffing and/or
budgetary support
Available resources: “the level of resources dedicated for implementation …including
money, training, education, physical space, and time” [13]
Multi-departmental participation in planning Process planning: “the degree to which scheme[s] … for implementing an intervention are
developed in advance and the quality of those schemes” [13]
Communication among team members, in or out
of meetings
Poor team communication Networks and communications: “the nature and quality of formal and informal
communications within an organization” [13]
Theme 3: Implementation facilitated by planners’ understanding of performance improvement, and fitting the new process into workflow
Planners with an understanding of the basic tenets of
performance improvement
Individuals’ other personal attributes: “personal traits such as tolerance of ambiguity, intellectual
ability, motivation, values, competence, capacity, and learning style” [13]
Fitting the process into each discipline’s workflow Compatibility: “how the intervention fits with existing workflows and systems” [13]
Assigning roles to multiple disciplines Resistance to changing roles and/or scope
of practice; enforcer is a negative role
Implementation climate: “The absorptive capacity for change, shared receptivity of involved
individuals to an intervention” [13]
Providing value to front-line providers to improve uptake Relative advantage: “stakeholders’ perception of the advantage of implementing the intervention
versus an alternative solution” [13]
Testing to optimize human-computer usability IT staff may not be available or able to
do testing
Trialability: “ability to test the intervention on a small scale in the organization, and to be
able to reverse course” [13]
Recognition that intervention should be refined based
on reevaluation
Trialability (see above for definition)




















Table 1 Themes, facilitators, and barriers to implementing medication reconciliation according to qualitative analysis of interviews with healthcare managers,
and selected relevant Consolidated Framework for Implementation Research (CFIR) constructs [13] (Continued)
Training all staff and tracking training Staff turnover high; non-compliance not al-
ways solved by retraining
Available resources (see above for definition)
Marketing campaign with slogan Networks and communications (see above for definition)
Successful training approaches: peer-to-peer training;
didactic with real case examples
Individuals’ knowledge and beliefs about the intervention (see above for definition)
Self-efficacy: “individuals’ belief in their own capabilities to execute course of action to
achieve implementation goals” [13]
Trainees’ experiencing first hand avoided errors to drive
home importance
Work and other activities compete for
trainees’ attention
Individual stage of change: “characterization of the phase an individual is in, as he or she
progresses toward skilled, enthusiastic, and sustained use of the intervention” [13]
Relative priority: “Individuals’ perception of the importance of the implementation” [13]
Theme 5: Planners monitored compliance to help sustain the process, but this did not ensure achievement of reduced errors
Monitoring of completion rates Completion rates provide no data on
health impact; lack of resources to gather
such data
Executing: “carrying out or accomplishing the implementation according to plan” [13]
Available resources (see above for definition)
Feedback of monitoring results to providers; fostering
competition to increase compliance
Dilemma that error reports could go up if
the new process results in more
recognition
Reflecting and evaluating: “quantitative and qualitative feedback about the progress and
quality of implementation accompanied with regular personal and team debriefing about
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Medical Officer. Respondents indicated that implemen-
tation was facilitated by planning team members who
were or became champions of the medication reconcili-
ation process.
A key functional characteristic of the planning team was
ease of communication. Respondents indicated openness
to others’ perspectives and willingness to compromise,
both of which facilitated discussion and joint problem-
solving. Commitment of members to the planning process
was high. Many respondents commented that, in the be-
ginning, meetings were scheduled at least weekly in order
to create momentum and facilitate rapid trouble-shooting.
Open channels of communication outside of the meetings
were equally important.
Implementation was facilitated by planning members
who were perceived as compelling leaders and who
could get cooperation from front line staff:
Buy-in is extremely important - getting principals and
strong people on the committee. People who are good
at convincing …. You have to have a provider onboard
if you expect the residents and the other attendings to
go with it (Pharmacist Manager).
Having organizationally well-positioned planning team
members was important when it came to obtaining re-
sources, which was often noted as a barrier. Statements
indicated that planning team members persevered to ob-
tain the necessary resources, even when faced with admin-
istrators who were reluctant to allocate them: “I know
how to push some buttons and I probably pushed some
buttons if I needed to [get administrators] onboard”
(Pharmacist Manager). “There was no budget for this and
there were no resources….. [So the project was accom-
plished by] whatever we could grab…. It was on our time”
(Physician Manager).
These quotes underscore the importance of en-
gaging champions, opinion leaders, and individuals;
the organizational “learning climate”; available resources;
and communications, all core CFIR constructs (Table 1),
and their contribution to the medication reconciliation
planning process.
Theme 3
Planners’ approach to implementation was facilitated by
understanding the need to fit the new process into work-
flow and to revise the process as needed, basic tenets of
performance improvement.
Respondents recognized a need to fit the new medica-
tion reconciliation process into the hospital’s existing staff-
ing structure and multiple disciplines’ different workflows
(the CFIR construct of “compatibility”) (Table 1). Initially
each discipline’s medication management workflow wasexamined, after which each discipline’s role in the new
medication reconciliation process was proposed. Respon-
dents noted that physicians were the ultimate decision
makers and that completing medication reconciliation is
part of their hospital admission process. However, each
organization assigned varying roles to other disciplines. In
one case, pharmacists were assigned to be present on the
patient care units to educate the patients and talk with the
doctors. This was considered to be a transformative role
change:
We used to have pharmacists work centrally and
verify the orders remotely and we changed the
paradigm and sent pharmacists to the floors. So
now… every unit has a pharmacist during the day
(Pharmacist Manager).
Yet, the limits of the pharmacist’s new role was also
articulated:
As a pharmacist, it's not in my scope of practice to
decide this versus this. It's within my scope to make
recommendation based on what I'm seeing but it's up
to the provider in the end to make that final decision
(Pharmacist Manager).
In another case of changing traditional roles, respon-
dents decided that nurses could input medication infor-
mation into the medication reconciliation record before
the physicians did. This created a multi-disciplinary ap-
proach to the medication reconciliation process with the
added unexpected, benefit of increased communication
among all providers:
I think it promotes communication between the
doctors and the nurses …. Many times patients tell
nurses things they don’t tell doctors and vice versa
(Nurse Manager).
Respondents expressed that increasing work efficiency
was an important facilitator of uptake by providers:
We tried to offer something of value. For the
physicians… no typing in meds or anything, its click,
click, click, do a little editing and you get this
beautiful discharge summary …. For the nurse, you
don’t have to write down your own list on admission
or on discharge, you just click, accept, and get what
you need for patients…. I think that was pretty
important to people that it helped them do the work
they were already doing (Physician Manager).
Respondents also recognized that implementation is
dynamic. They recognized that the process would be
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adapted. Several described an initial piloting in which
they watched an early user navigate the process and
then adjusted the process to better accommodate users
(the CFIR construct of “trialability” (Table 1)).
Theme 4
Staff training was recognized to be an important part of
rolling out and sustaining the process, but training has
limited effect on some individuals or groups.
Several training approaches were reported, including
didactic presentations during staff orientation, online
learning, presentations at departmental in-services and
conferences, and one-to-one training by peers. Training
occurred on all shifts and respondents reported the cre-
ation of tracking systems to ensure everyone involved
was trained. Promotion of the new process among pro-
viders was facilitated by a marketing campaign with the
slogan, “One list. One process. Universal access.”
Real near-miss case examples were presented to pro-
viders to demonstrate how medication reconciliation can
affect outcomes. There was recognition of the import-
ance of new users’ experiencing the benefit first hand in
order to drive home the importance of complying with
the new medication reconciliation process:
They don’t see a value until they come across the case
where they picked up a mistake and then they say,
‘Oh thank God we had this because look at what I
caught.’ [When] they've had that firsthand experience
of capturing something, that brings it home to them
(Pharmacist Manager).
Respondents also reported limitations to training ap-
proaches. First, staff turnover, especially of house staff
and trainees, was high, and rotations short, resulting in
insufficient time to solidify practice habits. Work and
other training activities competed for staff attention.
One respondent described an abbreviated “see one, do
one, teach one” approach to the new medication recon-
ciliation process. One respondent made the observation
that lapses in compliance cannot always be attributed to
inadequate training, nor corrected by more training:
Training is training. Performance is performance.
There's a link but you've got to be very careful in
always blaming training…. at some point the adult
learner has to take training and use it…. You've got to
hold people accountable (Nurse Manager).
These quotes reflect recognition that training’s impact
depends on the educational phase an individual is in, an
individual’s perception of the importance of medication
reconciliation, and the concept of self-efficacy. Thistheme is consistent with the core CFIR construct of the
influence of “individuals’ belief in their own capabilities
to execute course of action to achieve implementation
goals” (Table 1).
Theme 5
Planners monitored compliance to help sustain the new
process, but acknowledged that this did not ensure that
medication reconciliation was actually achieving its pri-
mary goal of reducing errors.
Most respondents indicated that monitoring of com-
pletion rates helped ensure that providers were complet-
ing medication reconciliation appropriately. They agreed
that the best way to ensure compliance was via direct
feedback of monitoring data to providers, to hold pro-
viders accountable, and to enable managers to reach out
to providers individually, part of the CFIR construct of
“reflecting and evaluating” (Table 1). Another respond-
ent believed that competition among units or teams
could facilitate increased compliance.
However, many also respondents noted that comple-
tion rates do not provide information on the quality of
the medication reconciliation process or error avoidance.
The central problem, as described by one respondent, is
that “We’re not collecting a gold standard medication
list, and comparing it to what people enter into the sys-
tem. We don’t have the infrastructure for that” (Phys-
ician Manager). This individual leaves open the question
of whether execution (“carrying out or accomplishing
the implementation according to plan,” a core CFIR con-
struct, Table 1) has actually been achieved. Another re-
spondent agreed:
We’re not … doing what really … should be
happening which is … a continuous process where
we’re gathering data in a consistent way and
measuring our progress against it and deciding
whether that data is meaningful for patient care. It’s
easy to gather numbers – compliance – but whether
or not that means patient’s lives are better, or errors
are reduced, is much harder (Another Physician
Manager).
Respondents acknowledged that ADE reports could go
down if the medication reconciliation process was suc-
cessful in preventing them, or, paradoxically, go up if the
new process resulted in increased recognition and
reporting of them, thereby creating a safety reporting
dilemma.
Discussion
In this study, we describe the implementation of medica-
tion reconciliation at two hospitals through analysis of
semi-structured interviews with individuals instrumental
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agreed that the purpose of medication reconciliation is
to improve patient safety by reducing medication errors
and ensure compliance with the Joint Commission Na-
tional Patient Safety Goal. Planning process characteris-
tics emphasized by the respondents included: assembling
an interdisciplinary team, getting buy-in from adminis-
trators and clinical leaders, fitting the new process into
providers’ existing workflow, and providing value to pro-
viders assigned to key roles. Assignment of roles was a
decision that required discussion and compromise dur-
ing the planning process. Overall, key qualities of plan-
ning team members included a significant stake in the
outcome, cooperative spirit and willingness to com-
promise and embracing challenges associated with solv-
ing a complex problem.
Results of the current study indicated that planners
understood tenets of performance improvement, and
followed steps akin to a Plan-Do-Study-Act (PDSA)
model. PDSA is a change model consisting of the fol-
lowing steps: developing a plan to implement and test
the change (Plan), carrying out the change (Do), observ-
ing and learning from the consequences (Study), and
determining what modifications should be made (Act)
[19]. Our study included statements that indicated ac-
ceptance of an imperfect process at the beginning followed
by process refinement, fitting the process into existing
workflow to the extent possible, use of teaching and mar-
keting to generate acceptance of the process by users, and
subsequent monitoring of and feedback on process per-
formance. Use of a PDSA approach is notable because
medication reconciliation may be more difficult to imple-
ment than other performance improvement interventions,
as demonstrated by the history of pushback against the
Joint Commission National Patient Safety Goal by many or-
ganizations [8]. Whether adaptation and promotion of the
PDSA approach specifically for this process could improve
its implementation is an open question.
Respondents indicated that there were some important
role changes or adjustments that were expected of pro-
viders. For physicians, the introduction of medication
reconciliation forced focused consideration of the pa-
tient’s entire list of medical problems and treatments.
For pharmacists, transformative roles required pharma-
cists to spend more time on the hospital units reviewing
medications with patients before discharge and inter-
facing with medical and nursing providers. This finding
is consistent with other studies, which have reported on
role changes of similar magnitudes for physicians, phar-
macists, and nurses involving medication reconciliation
such as having hospital nurses, pharmacists or pharmacy
technicians play a larger role in taking medication his-
tories [20,21]. Yet studies also report significant barriers
to providers’ accomplishing the new tasks, includingunreliable sources of medication information and tasks
that compete for providers’ time and attention that they
consider higher priority. As a result providers are at risk
for having low self-efficacy; i.e., low perceived capability
to achieve the process’ objectives [22].
Our study produced some unanticipated findings. First,
although respondents were unanimous that the purpose
medication reconciliation was to decrease errors, monito-
ring efforts focused on completion of the medication recon-
ciliation process (i.e., compliance), with limited resources
allocated to monitoring its accuracy or effectiveness (i.e., ef-
fect on medication errors). This is important because, in a
previous study we found that providers who were complet-
ing medication reconciliation did not have confidence that
the process was sufficient to prevent errors and ADEs as
intended and their attitudes toward the process were often
negative [22]. Other authors have noted the insufficiency of
simply monitoring compliance [12] and at least one safety
advocacy group has promoted a measure called the Medi-
cation Reconciliation Success Index (MRSI), which is a
measure of avoidance of unintended discrepancies adjusted
for the total number of pre-hospital medications [MRSI =
1-(number of unintended discrepancies/number of pre-
hospital medications)] [23].
Second, the majority of the suggestions for improving
the medication reconciliation process were hospital, pro-
vider, or departmental measures, and not driven by consid-
ering the patient’s experience. Patient-centered comments
were rare, potentially in part because we did not ask about
the patient experience. Yet improving the patient experi-
ence with medication reconciliation could have a positive
impact on medication-related outcomes and patient satis-
faction. One emerging patient-centered measurement tool,
the Care Transitions Measure, explicitly asks patients or
family members whether they received all the information
needed to manage their medications upon discharge from
the hospital [24]. Knowing the effect of medication recon-
ciliation on health care utilization such as hospitalization is
also important to patients, providers, and planners. Al-
though studies to date have not shown a consistent effect,
this may be because of the design of the medication recon-
ciliation intervention studied or because other factors had
greater influence on hospital utilization [6].
A strength of this study is that it follows our prior
studies in same setting, and our interview script, coding,
and analysis were informed by prior data and experience
[22,25]. In this regard, a limitation of the study is that
one author (KSB) was a member of the participating or-
ganizations during medication reconciliation planning
and implementation, which may have influenced data
collection and interpretation. However, this was not the
case for the remaining authors. Results of this study
were also shown to be consistent with constructs in an
implementation model, the CFIR Table 1) [13]. Categories
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characteristics (e.g., relative advantage, trialability),
inner setting (e.g., networks and communications, im-
plementation climate, compatibility, relative priority,
goals and feedback, learning climate, available re-
sources), characteristics of individuals (e.g., knowledge
and beliefs about the intervention, self-efficacy, in-
dividual stage of change), and process (e.g., planning,
engaging opinion leaders, engaging champions, execut-
ing, and reflecting and evaluating). Consistency with
this framework shows how medication reconciliation
implementation is similar to other implementation
problems, and also shows gaps in research on the topic
that should be pursued in future studies. A limitation
of our study is that we applied CFIR framework retro-
spectively, and there are areas that we did not purpose-
fully query, such as structural characteristics of the
organization.
Conclusion
In this qualitative study, planners of medication re-
conciliation described resource-intensive planning and
implementation, acknowledged multiple challenges in-
volved in these processes, and revealed a good under-
standing of performance improvement principles. Our
findings suggest approaches that may improve the like-
lihood of medication reconciliation implementation
success, and include constructs from established im-
plementation models (i.e., PDSA and CFIR). Planners
also need to understand provider perceptions of the
new process, especially providers’ perceived capability
to achieve the process’ objectives. The following ap-
proaches may be particularly useful to improve the
likelihood of successful planning and implementation
of medication reconciliation:
1) Involve a multidisciplinary planning team consisting
of highly-respected individuals who are open to
change and compromise
2) Recognize that effective medication reconciliation
may not be achieved by just refining existing
practice and that significant professional role
changes may be necessary, especially for nursing and
pharmacy staff
3) Recognize the need to trial the new process and
refine it
4) Recognize and promote other benefits of the
process, such as enhanced communication between
disciplines
5) Plan to devote resources not just to compliance
monitoring but also to monitoring of the process’
impact on prescribing in order to be able to provide
clinically meaningful evidence of the impact of the
process to front-line providersCompeting interests
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